References:
1. Groß R, Conzelmann C, Müller JA, Stenger S, Steinhart K, Kirchhoff F, et al. Detection of SARS-CoV-2 in human breastmilk. Lancet Lond Engl. 2020 Jun 6;395(10239):1757–8.
2. Buonsenso D, Costa S, Sanguinetti M, Cattani P, Posteraro B, Marchetti S, et al. Neonatal Late Onset Infection with Severe Acute Respiratory Syndrome Coronavirus 2. Am J Perinatol. 2020 Jun;37(8):869–72.
3. Kirtsman M, Diambomba Y, Poutanen SM, Malinowski AK, Vlachodimitropoulou E, Parks WT, et al. Probable congenital SARS-CoV-2 infection in a neonate born to a woman with active SARS-CoV-2 infection. CMAJ Can Med Assoc J J Assoc Medicale Can. 2020 Jun 15;192(24):E647–50.
4. Tam PCK, Ly KM, Kernich ML, Spurrier N, Lawrence D, Gordon DL, et al. Detectable Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Human Breast Milk of a Mildly Symptomatic Patient With Coronavirus Disease 2019 (COVID-19). Clin Infect Dis Off Publ Infect Dis Soc Am. 2021 Jan 23;72(1):128–30.
5. Timeline: WHO’s COVID-19 response [Internet]. [cited 2021 Mar 1]. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/interactive-timeline
6. Chen H, Guo J, Wang C, Luo F, Yu X, Zhang W, et al. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. The Lancet [Internet]. 2020 Feb 12 [cited 2020 Feb 25];0(0). Available from: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30360-3/abstract
7. Lackey KA, Pace RM, Williams JE, Bode L, Donovan SM, Järvinen KM, et al. SARS-CoV-2 and human milk: what is the evidence? MedRxiv Prepr Serv Health Sci. 2020 Apr 11;
8. Rajewska A, Mikołajek-Bedner W, Lebdowicz-Knul J, Sokołowska M, Kwiatkowski S, Torbé A. COVID-19 and pregnancy - where are we now? A review. J Perinat Med. 2020 Jun 25;48(5):428–34.
9. Goldman AS, Garza C, Nichols BL, Goldblum RM. Immunologic factors in human milk during the first year of lactation. J Pediatr. 1982 Apr;100(4):563–7.
10. Dong Y, Chi X, Hai H, Sun L, Zhang M, Xie W-F, et al. Antibodies in the breast milk of a maternal woman with COVID-19. Emerg Microbes Infect. 2020 Dec;9(1):1467–9.
11. Demers-Mathieu V, Do DM, Mathijssen GB, Sela DA, Seppo A, Järvinen KM, et al. Difference in levels of SARS-CoV-2 S1 and S2 subunits- and nucleocapsid protein-reactive SIgM/IgM, IgG and SIgA/IgA antibodies in human milk. J Perinatol Off J Calif Perinat Assoc. 2020 Sep 1;
12. Fox A, Marino J, Amanat F, Krammer F, Hahn-Holbrook J, Zolla-Pazner S, et al. Evidence of a significant secretory-IgA-dominant SARS-CoV-2 immune response in human milk following recovery from COVID-19. medRxiv. 2020 May 8;2020.05.04.20089995.
13. Lebrão CW, Cruz MN, Silva MH da, Dutra LV, Cristiani C, Affonso Fonseca FL, et al. Early Identification of IgA Anti-SARSCoV-2 in Milk of Mother With COVID-19 Infection. J Hum Lact Off J Int Lact Consult Assoc. 2020 Nov;36(4):609–13.
14. Gao X, Wang S, Zeng W, Chen S, Wu J, Lin X, et al. Clinical and immunologic features among COVID-19-affected mother-infant pairs: antibodies to SARS-CoV-2 detected in breast milk. New Microbes New Infect. 2020 Sep;37:100752.
15. Fox A, Marino J, Amanat F, Krammer F, Hahn-Holbrook J, Zolla-Pazner S, et al. Robust and Specific Secretory IgA Against SARS-CoV-2 Detected in Human Milk. iScience. 2020 Nov 20;23(11):101735.
16. Pace RM, Williams JE, Järvinen KM, Belfort MB, Pace CDW, Lackey KA, et al. Characterization of SARS-CoV-2 RNA, Antibodies, and Neutralizing Capacity in Milk Produced by Women with COVID-19. mBio. 2021 Feb 9;12(1).
17. Merino P, Guinea J, Muñoz-Gallego I, González-Donapetry P, Galán JC, Antona N, et al. Multicenter evaluation of the PanbioTM COVID-19 rapid antigen-detection test for the diagnosis of SARS-CoV-2 infection. Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis. 2021 Feb 16;
18. Lamouroux A, Attie-Bitach T, Martinovic J, Leruez-Ville M, Ville Y. Evidence for and against vertical transmission for severe acute respiratory syndrome coronavirus 2. Am J Obstet Gynecol. 2020 Jul;223(1):91.e1-91.e4.
19. Wu Z, McGoogan JM. Characteristics of and Important Lessons from the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72314 Cases from the Chinese Center for Disease Control and Prevention. Vol. 323, JAMA - Journal of the American Medical Association. American Medical Association; 2020. p. 1239–42.
20. Robinson HP, Fleming JE. A critical evaluation of sonar ‘crown-rump length’ measurements. Br J Obstet Gynaecol. 1975 Sep;82(9):702–10.
21. Beavis KG, Matushek SM, Abeleda APF, Bethel C, Hunt C, Gillen S, et al. Evaluation of the EUROIMMUN Anti-SARS-CoV-2 ELISA Assay for detection of IgA and IgG antibodies. J Clin Virol Off Publ Pan Am Soc Clin Virol. 2020 Aug;129:104468.
22. Nicol T, Lefeuvre C, Serri O, Pivert A, Joubaud F, Dubée V, et al. Assessment of SARS-CoV-2 serological tests for the diagnosis of COVID-19 through the evaluation of three immunoassays: Two automated immunoassays (Euroimmun and Abbott) and one rapid lateral flow immunoassay (NG Biotech). J Clin Virol Off Publ Pan Am Soc Clin Virol. 2020 Aug;129:104511.
23. Cleveland WS, Grosse E, Shyu WM. Local Regression Models. In: Statistical Models in S. Routledge; 1992.
24. Core Team. R: A language and environment for statistical computing. 2020. Available from: https://www.R-project.org/
25. Jason JM, Nieburg P, Marks JS. Mortality and infectious disease associated with infant-feeding practices in developing countries. Pediatrics. 1984 Oct;74(4 Pt 2):702–27.
26. Hanson LA. Human milk and host defence: immediate and long-term effects. Acta Paediatr Oslo Nor 1992 Suppl. 1999 Aug;88(430):42–6.
27. Kovar MG, Serdula MK, Marks JS, Fraser DW. Review of the epidemiologic evidence for an association between infant feeding and infant health. Pediatrics. 1984 Oct;74(4 Pt 2):615–38.
28. Castilla J, Pintado B, Sola I, Sánchez-Morgado JM, Enjuanes L. Engineering passive immunity in transgenic mice secreting virus-neutralizing antibodies in milk. Nat Biotechnol. 1998 Apr;16(4):349–54.
29. Jawhara S. Can Drinking Microfiltered Raw Immune Milk From Cows Immunized Against SARS-CoV-2 Provide Short-Term Protection Against COVID-19? Front Immunol. 2020;11:1888.
30. Low JM, Low YW, Zhong Y, Lee CYC, Chan M, Ng NBH, et al. Titres and neutralising capacity of SARS-CoV-2-specific antibodies in human milk: a systematic review. Arch Dis Child Fetal Neonatal Ed. 2021 Jul 13;fetalneonatal-2021-322156.
31. Pace RM, Williams JE, Järvinen KM, Belfort MB, Pace CD, Lackey KA, et al. COVID-19 and human milk: SARS-CoV-2, antibodies, and neutralizing capacity. MedRxiv Prepr Serv Health Sci. 2020 Sep 18;2020.09.16.20196071.
32. Larson BL, Heary HL, Devery JE. Immunoglobulin production and transport by the mammary gland. J Dairy Sci. 1980 Apr;63(4):665–71.
33. Brandtzaeg P, Farstad IN, Haraldsen G, Jahnsen FL. Cellular and molecular mechanisms for induction of mucosal immunity. Dev Biol Stand. 1998;92:93–108.
34. Mestecky J. The common mucosal immune system and current strategies for induction of immune responses in external secretions. J Clin Immunol. 1987 Jul;7(4):265–76.
35. Nathavitharana KA, Catty D, McNeish AS. IgA antibodies in human milk: epidemiological markers of previous infections? Arch Dis Child Fetal Neonatal Ed. 1994 Nov;71(3):F192-197.
36. Post N, Eddy D, Huntley C, van Schalkwyk MCI, Shrotri M, Leeman D, et al. Antibody response to SARS-CoV-2 infection in humans: A systematic review. PloS One. 2020;15(12):e0244126.
37. Goad J, Rudolph J, Rajkovic A. Female reproductive tract has low concentration of SARS-CoV2 receptors. BioRxiv Prepr Serv Biol. 2020 Jun 22;
TABLES
Table 1. Maternal, pregnancy and disease characteristics.
Table 2. Human breast milk and maternal blood serology.
Table 3. Presence of immunoglobulins in human colostrum according to the trimester of the acute infection of SARS-CoV-2.
Table 4. Correlation between antibodies present in breast milk and maternal blood.
Figure 1. Samples flow chart
Figure 2. Correlation between immunoglobulin levels in colostrum and maternal blood. IgM, IgA and IgG are represented in figures 2a, 2b and 2c, respectively.
Figure 3. Correlation between immunoglobulin levels in mature breast milk and maternal blood. IgM, IgA and IgG are represented in figures 3a, 3b and 3c, respectively.
Figure 4. Correlation between immunoglobulin levels in colostrum and severity of COVID-19 disease. IgA and IgG are represented in figures 4a and 4b, respectively.